ARCHIVES

Roferon A Application Marred By Mission Data, Protocol, Compliance

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

Biomedical Panel To Hear Public At Sept. Meeting

July 11, 1975

FCRF Contracts Hit $40.3 Million With Transfer Of Labs From NIH, Elsewhere

October 8, 1982

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

Senate Committee Investigating Pharma’s “Educational Grants.”

January 20, 2006

Seventeen of 23 CHOPs Approved For Implementation

July 16, 1982

In Brief: NCI Providing Information On Levamisole To Patients; Macdonald Jins Temple, Salick

July 21, 1989